Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
, 31 (3), 189-91

Clinical Research on Zishengukang Pill (See Text) Used to Treat Delayed Union of Fracture

Affiliations
Randomized Controlled Trial

Clinical Research on Zishengukang Pill (See Text) Used to Treat Delayed Union of Fracture

Zhen-Jun Huang et al. J Tradit Chin Med.

Abstract

Objective: To observe the curative effect of Zishengukang Pill (see text) on delayed union of fracture.

Methods: Sixty-four patients with delayed union of fracture were randomly divided into a control group of 32 cases treated with Western medicine and a treatment group of 32 cases treated with Western medicine and Zishengukang Pill. After 3 courses of treatment with 30 days as a course, the curative effects in the two groups were evaluated and their clinical symptoms, union rate and union time of fracture were compared.

Results: The treatment resulted in cure in 25 cases, improvement in 6 cases and ineffectiveness in 1 case with the effective rate at 96.8% in the treatment group, higher than 81.3% in the control group (P < 0.05). The union rate of fracture in the treatment group was higher than that in the control group (34.3% vs. 12.5%, P < 0.05). The union time of fracture in the treatment group was shorter than that in the control group ((4.0 +/- 1.7) months vs. (5.0 +/- 1.4) months, P < 0.05).

Conclusion: Zishengukang Pill with obvious curative effect in the treatment of delayed union of fracture is worth popularizing.

Similar articles

See all similar articles

Cited by 1 PubMed Central articles

Publication types

Substances

LinkOut - more resources

Feedback